2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Treatment Considerations, Combination Therapy, Drug Development, Supportive Care, Biological Therapies, Transfusion, Non-Biological Therapies, Devices, Pharmacology, Women’s Health, Adverse Events, Artificial Intelligence (AI), Computer Vision, Machine Learning, Biological Processes, Genomics, Immune Mechanism, Clinical Practice (Health Services and Quality), Patient Safety, Quality of Care, Systems-Based Hematology, Value, Diseases, Genetic Disorders, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Trait, Thalassemia, Infectious Diseases, Viral, Bacterial, Research, Translational Research, Clinical Research, Clinical Trials, Epidemiology, Health Outcomes Research, Real-World Evidence, Study Population, Human, Adult, Embryo/Fetus, Pediatric, Pregnant, Young Adult
PAPER

1192 Cardiorenal phenotypic divergence during mid-adolescence in sickle cell disease: Preliminary Results from the drepakid study

Thomas d'Humieres, MD, PhD, Luu-Ly Pham, MD, PhD2, Claire Dossier, MD3, Marine Houlier, MD4, Lahoueri Amor Chelihi, MD5, Antonio Morabito, MD6, Nabil BELAID7, Gonzalo De Luna, MD8, Anoosha Habibi, MD/ Associated Professor9, Vincent Audard10, Pablo Bartolucci, MD, PhD11, Sylvain LE Jeune, MD/PhD12
1 Henri Mondor Teaching Hospital, Créteil, France
2 Avicenne Hospital, Bobigny, France
3 Robert Debré Hospital, Paris, France
4 Jean Verdier Hospital, Bondy, France
5 Jean Verdier Hospital, Bondy, France
6 Avicenne Hospital, Bobigny, France
7 Avicenne Hospital, Bobigny, France
8 Henri Mondor Teaching Hospital, Créteil, France
9 Henri Mondor Teaching Hospital, Créteil, France
10 Henri Mondor Teaching Hospital, Créteil, France
11 Henri Mondor Teaching Hospital, Créteil, France
12 Avicenne Hospital, Bobigny, France

Background: Cardiorenal complications are major determinants of morbidity and mortality in adults with sickle cell disease (SCD), yet their origins likely begin during childhood. Identifying children at risk remains challenging because physiological maturation and early pathological remodeling occur simultaneously. Consequently, age-related changes in myocardial relaxation and renal function may reflect either normal developmental trajectories or the earliest manifestations of cardiorenal disease. We hypothesized that increasing interindividual variability in cardiac and renal function during growth reflects the emergence of distinct cardiorenal phenotypes before adulthood.

Methods: Preliminary data from an ongoing multicenter French cohort including 180 children and young adults (5–25 years) with sickle cell disease were screened. The present analysis included 79 HbSS/Sβ° patients with simultaneous assessment of cardiac diastolic and renal function. Cardiac evaluation included lateral mitral annular e′ velocity and cardiac index, while renal function was estimated using the CKiD-U25 equation. To identify the age at which cardiorenal phenotypes begin to diverge, age-related changes in interindividual variability were explored using scatterplots and rolling standard deviation analyses, and formally assessed across candidate age thresholds (14, 15 and 16 years) using Levene and Fligner–Killeen tests. As exploratory analyses consistently identified mid-adolescence as the period of greatest increase in variability, patients aged ≥15 years were subsequently analyzed by unsupervised K-means clustering using standardized hemoglobin, LDH, cardiac index (CI), eGFR and lateral e′. The study was approved by the local ethics committee (CLEA-2025-465).

Results: The study included 79 children, adolescents and young adults with HbSS/Sβ° sickle cell disease (mean age 18.0 ± 5.1 years; 44% female; 85% receiving hydroxyurea). Exploratory analyses identified mid-adolescence as a period of selective cardiorenal phenotypic divergence. Interindividual variability of lateral mitral annular e′ increased significantly at both the 14- and 15-year thresholds (Levene & Fligner P=0.003–0.005), whereas eGFR exhibited the same directional pattern with a more gradual increase in variability. In contrast, CI showed no age-related increase in variance, while LDH displayed the opposite pattern, with greater variability in younger patients, indicating that phenotypic divergence was specific to cardiorenal remodeling rather than reflecting generalized biological variability. To determine whether this increasing variability reflected structured biological phenotypes, unsupervised clustering was performed in patients aged ≥15 years and identified three distinct cardiorenal phenotypes. Importantly, clusters did not differ in age, sex, or hydroxyurea exposure.

The first phenotype combined severe hemolysis (Hb 8.6 g/dL; LDH 684 U/L), marked hyperdynamic circulation (cardiac index 4.6 L/min/m²), glomerular hyperfiltration (eGFR 180 mL/min/1.73 m²), impaired myocardial relaxation (lateral e′ 14.5 cm/s), higher E/e′ ratio, and lower BMI. Notably, it was the only phenotype associated with a history of leg ulcers (27% vs. 0% vs. 0%; P=0.002), providing independent clinical validation of a severe cardiorenal phenotype.

The second phenotype displayed higher hemoglobin, lower hemolysis, lower cardiac output, preserved diastolic function and the highest BMI, consistent with a compensated cardiorenal profile.

The third phenotype remained hyperdynamic despite preserved myocardial relaxation and intermediate hemolysis. It was additionally characterized by lower bicarbonate concentrations and higher leukocyte counts, suggesting persistent renal tubular involvement despite preserved myocardial function and raising the possibility of a biologically resilient cardiac phenotype.

Conclusion: These preliminary findings identify mid-adolescence as a critical window of biological divergence in sickle cell disease, during which distinct cardiorenal phenotypes become apparent. Increasing interindividual variability may therefore represent an early marker of phenotypic emergence, providing a novel framework to study early cardiorenal remodeling before overt clinical disease. Longitudinal follow-up will determine whether these phenotypes predict subsequent cardiovascular and renal outcomes and can refine individualized risk stratification during the transition to adult care.

Thomas d'Humieres, MD, PhD: No relevant conflicts of interest to declare.